ConvaTec, GB00BD3VFW73

ConvaTec stock rises 0.4% after Kepler starts coverage

Published on 08/27/2026 at 15:48 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

ConvaTec stock is up 0.4% at 228.4 pence after Kepler started coverage with Buy and a 286 pence target. The note points to about 7% growth and mid-20% margins.

Flatlay mit Aktienzertifikat, ISIN-Karte, Wundauflagen und Stethoskop von oben
ConvaTec Group Plc GB00BD3VFW73 arrangiert Flatlay mit Aktienzertifikat, ISIN-Karte und medizinischen Wundversorgungsutensilien übersichtlich, Illustration mit AI erstellt.

ConvaTec Group plc (GB00BD3VFW73) stock traded at 228.4 pence, up 0.4%, after Kepler Cheuvreux started coverage with a Buy rating and a 286 pence target on August 27, 2026.

That note is built on a forecast for about 7% growth, improving free cash flow and EPS growth in the low teens, while ConvaTec's shares also lagged the FTSE 250's roughly 0.6% advance on the same session.

Coverage starts with a clear view

The new call from Kepler frames the investment case around operating recovery rather than a one-off event, and it puts a concrete valuation anchor on the shares. The target implies 57.6 pence of upside from 228.4 pence, before dividends or any change in the growth view.

For investors, the key comparison is simple: a 0.4% move in the stock versus a broader 0.6% move in the benchmark, alongside a broker model that expects mid-20% margins and a low-teens EPS trajectory.

What the model implies

Kepler's view is directional, but it is also numerical. The brokerage is looking for about 7% growth, stronger free cash flow and margins in the mid-20% range, which gives the stock a current story that can be checked against execution rather than sentiment.

The market reaction was modest, not dramatic, but it still left ConvaTec below the wider FTSE 250 on the day. That gap matters because the new coverage arrives with a specific target and a defined operating path.

Read more

The Kepler coverage note is the day's main catalyst.

ConvaTec's core business

ConvaTec sells products for wound care, ostomy care, continence care and infusion care, so its turnaround case depends on both volume and operating discipline. That mix is why margin, cash flow and growth expectations sit at the center of the new broker call.

Price and profile

ConvaTec shares were last quoted at 228.4 pence on August 27, 2026. The move left the stock 0.4% higher in the session and 57.6 pence below the 286 pence target.

Fact box

Company: ConvaTec Group plc
ISIN: GB00BD3VFW73
Ticker: CTEC
Exchange: London Stock Exchange
Price (as of August 27, 2026): GBP 2.284
Sector / Industry: Health Care / Health Care Equipment & Supplies

Disclaimer...

en | GB00BD3VFW73 | CONVATEC | boerse | 70009041 | bgmi